Science Explorer Interactive view Map
Company · Jílové u Prahy · Czechia

BIOPHARM (Czechia)

bri.cz/enROR OpenAlex
Research works
19
▼ 63% vs 2013–17
Citations
453
23.6 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: BIOPHARM (Czechia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.79× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 18.92× its world share, 0 worksImmunology and Micro…Neuroscience: 4.40× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 47.29× its world share, 0 worksPharmacology, Toxico…Chemistry: 4.55× its world share, 0 worksChemistryEngineering: 0.63× its world share, 0 worksEngineeringMaterials Science: 2.05× its world share, 0 worksMaterials ScienceMedicine: 1.24× its world share, 0 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 47.3×. Every wedge is a field page.

Which research topics does BIOPHARM (Czechia) publish most on?

By volume in 2022–2025: Drug Solubulity and Delivery Systems, Monoclonal and Polyclonal Antibodies Research, Crystallization and Solubility Studies and Congenital gastrointestinal and neural anomalies.

Drug Solubulity and Deli…0Drug Solubulity and Delivery Systems: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksCrystallization and Solubility Studies: 0 fractional worksCongenital gastrointestinal and neural anomalies: 0 fractional worksAnalytical Methods in Ph…0Analytical Methods in Pharmaceuticals: 0 fractional worksProtein purification and stability: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksImmunodeficiency and Aut…0Immunodeficiency and Autoimmune Disorders: 0 fractional worksInjection Molding Process and Properties: 0 fractional worksNeurogenesis and neuroplasticity mechanisms: 0 fractional works
Pharmaceutical ScienceRadiology, Nuclear Medicine and ImagingMaterials ChemistrySurgery5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Crystallization and Solubility Studies Materials Chemistry 0 works
  4. 4 Congenital gastrointestinal and neural anomalies Surgery 0 works
  5. 5 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
  6. 6 Protein purification and stability Molecular Biology 0 works
  7. 7 Immunotherapy and Immune Responses Immunology 0 works
  8. 8 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  9. 9 Injection Molding Process and Properties Mechanical Engineering 0 works
  10. 10 Neurogenesis and neuroplasticity mechanisms Developmental Neuroscience 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.5%not open53.5%

World: 28% of research is openly available.

with international co-authors28.7%domestic only71.3%

World: 19% is written across borders.

How has BIOPHARM (Czechia)'s research output changed?

Output in 2018–2022 was 63% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Jílové u Prahy

All research institutions in Jílové u Prahy

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.